Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast Cancer

NCT02031042 is registered in ClinicalTrials.gov with Stockholm South General Hospital as lead sponsor.

NCT NCT02031042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02031042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast Cancer
Lead sponsor
Stockholm South General Hospital
Phase
Observational
Overall status
Completed
Start date
October 31, 2010
Completion date
December 31, 2015
Enrollment
224 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer